10:46 AM EDT, 03/17/2017 (MT Newswires) --
Gainers in Continental Europe were led by Telefonica (TEF), a Spanish telecommunications group, 3.0% higher, followed by Ascendis Pharma (ASND), a Danish clinical stage biopharmaceutical company, up by 2.9% and AB InBev (BUD), a Belgian brewing company, up by 2.7%. Nokia (NOK), a technology investor, was 2.2% higher.
In the UK, Akari Therapeutics (AKTX), a development-stage biopharmaceutical company, was 7.6% higher, followed by Royal Bank of Scotland (RBS), up by 2.5% and Amarin (AMRN), a biopharmaceutical company, also 2.5% higher. Low-cost airline Ryanair (RYAAY) was up by 2.1%.
Decliners in Continental Europe were led by Nabriva Therapeutics (NBRV), an Austria-based clinical-stage biopharmaceutical company, 1.3% lower, followed by Deutsche Bank - Global Registered Shares (DB), 1.0% lower. Forward Pharma (FWP), a Danish biopharmaceutical company, and Sequans Communications (SQNS), a French developer of chipset solutions, were both 0.8% lower.
And, in the UK, Avadel (AVDL), a specialty pharmaceutical company, was 3.0% lower, followed by Amec Foster Wheeler (AMFW), a global engineering conglomerate, down by 2.2% and Pearson (PSO), an education company, 1.0% lower. Trinity Biotech (TRIB), a manufacturer of medical diagnostic products, was 0.7% lower.
Price: 11.33, Change: +0.10, Percent Change: +0.89
Copyright © 2017 MTNewswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.